Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives

John Maher1– 3 1King’s College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, Guy’s Cancer Centre, Great Maze Pond, London, SE1 9RT, UK; 2Leucid Bio Ltd., Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UK; 3Department of Immunology, Eastbourne Hospital, Kings Drive, East...

Full description

Bibliographic Details
Main Author: Maher J
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:OncoTargets and Therapy
Subjects:
immunotherapy
malignancy
engineered t-cell
pulmonary
Online Access:https://www.dovepress.com/chimeric-antigen-receptor-car-t-cell-therapy-for-patients-with-lung-ca-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/chimeric-antigen-receptor-car-t-cell-therapy-for-patients-with-lung-ca-peer-reviewed-fulltext-article-OTT

Similar Items